Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP39 activates invasion potential ovarian cancer cells. 2 / 2

| 2

➶

eidos

"D Matrigel invasion data showing that overexpression of USP39 significantly enhanced invasion capacity , whereas knockdown of USP39 ( sh-1 and sh-2 ) decreased the invasion potential of ovarian cancer cells ( n = 3 biologically independent samples ) ."

33731694

➶

eidos

"In addition , a transwell invasion assay revealed that forced expression of USP39 significantly enhanced the invasion capacity whereas knockdown of USP39 decreased the invasion potential of ovarian cancer cells ( Fig. 2D ) ."

33731694

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...